Opinion
Video
Author(s):
An expert discusses how the study assessed real-world effectiveness of tildrakizumab for moderate to severe plaque psoriasis, crucial for validating clinical trial results. Multisite data enhanced reliability, while a systematic review and meta-analysis confirmed efficacy, safety, and quality of life benefits, aligning with trial findings.
Video content above is prompted by the following:
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.